Skip to content
healthcare.dev

Methylphenidate Hydrochloride

NDC 62037-734, Methylphenidate Hydrochloride, tablet, film coated, extended release, from Actavis Pharma, Inc..

Product NDC
62037-734
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076772
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62037-734 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHYLPHENIDATE HYDROCHLORIDE27 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
62037-734-0162037073401100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62037-734-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/85ef422d-af27-4126-9841-6892af1871d6
  • NADAC price for package 62037073401

    GET /v1/drugs/nadac/62037073401

Use it

Look up 62037-734 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62037-734 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62037-734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.